Dr. Elizabeth Ginsburg

Dr. Elizabeth S. Ginsburg

Brigham & Women's Hospital, USA



1985 M.D., Mt. Sinai School of Medicine

1980 B.Sc., Wellesley College

Publications (selected)

  1. Partridge AH, Ruddy KJ, Gelber S, Schapira L, Abusief M, Meyer M, Ginsburg ES. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer.  Fertil Steril, 2010 Jul; 94(2): 638-44. Epub 2009 May 5.
  2. Robertson Ad, Missmer SA, Ginsburg ES. Embryo yield after in vitro fertilization in women undergoing embryo banking for fertility preservation before chemotherapy.
  3. Quaas AM, Missmer SA, Ginsburg ES. Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction-intrauterine insemination to in vitro fertilization conversions, independent of age and estradiol level on the day of human chorionic gonadotropin administration. Fertil Steril, 2010; 93(2): 605-608. Epub 2009 Mar 26.
  4. Ruddy KJ, Ginsburg ES, Schapira L, Meyer ME. Menopausal Symptoms and Fertility Concerns in Premenopausal Breast Cancer Survivors: A Comparison to Age and Gravidity-Matched Controls. The Journal of The North American Menopause Society, Jan 2011; Vol 18.1.
  5. Abusief ME, Missmer SA, Ginsburg ES, Weeks JC, Partridge AH. The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer. Cancer, 2010; 116(4): 791-798.
  6. Barton SE, Missmer SA, Ashby RK, Ginsburg ES. Multivariate analysis of the association between oocyte donor characteristics, including basal follicle stimulating hormone (FSH) and age, and IVF cycle outcomes. Fertil Steril, 2009, E pub.
  7. Huddelston HG, Racowsky C, Jackson KV, Fox JH, Ginsburg ES. Coasting vs. cryopreservation of all embryos prevention of ovarian hyperstimulation syndrome in IVF. Fertil Steril, 2008; 90(4): 1259-1262.
  8. Luke B, Brown MB, Grainger DA, Baker VL, Ginsburg ES, Stern JE, A SART Writing Group. The sex ratio of singleton offspring in assisted conception pregnancies. Fertil Steril, 2009; (92)5: 1579-85. Epub 2008.
  9. Partridge AH, Gelber S, Peppercorn J, Ginsburg ES, Sampson E, Rosenberg R, Przypyszny M, Winer EP. Fertility and menopausal outcomes in young breast cancer survivors. Clin Breast Cancer, 2008; 8(1): 65-69.
  10. Lerou PH, Yabuuchi A, Huo H, Takeuchi A, Shea J, Cimini T, Ince TA, Ginsburg ES, Racowsky C, Daley GQ.  Human embryonic stem cell derivation from poor-quality embryos. Nature Biotechnology, 2008; 26(2): 212-214.
  11. Estes SJ, Missmer SA, Ginsburg ES. Should a patient’s own IVF physician perform the embryo transfer? J Assist Reprod Genet, 2006; 23(5): 235-239.
  12. Racowsky C, Orasanu B, Hinrichsen MJ, Ginsburg ES. Embryo quality based on ovulation induction: defining the differences. Reprod Biomed Online, 2005; 11(1): 22-25.
  13. Combelles CM, Orasanu B, Ginsburg ES, Racowsky C. Optimum number of embryos to transfer in women more than 40 years of age undergoing treatment with assisted reproductive technologies. Fertil Steril, 2005; 84(6): 1637-1642.
  14. Ginsburg ES, Xiao L, Gargiulo AR, Kung FT, Politch JA, Schust DJ, Hill, JA. T-helper 2 and 3 type immunity to trophoblast in successful in vitro fertilization-embryo transfer. Fertil Steril, 2005; 83(6): 1659-1664.
  15. Styer AK, Jackson KV, Hornstein MD, Racowsky C, Ginsburg ES, Gargiulo AR. Pregnancy outcomes in in vitro fertilization cycles with serum estradiol drop prior to human chorionic gonadotropin. Int J Gynaecol Obstet, 2005; 89: 133-137.
  16. Srouji SS, Mark A, Levine Z, Betensky RA, Hornstein MD, Ginsburg ES. Predicting in vitro fertilization live birth using stimulation day 6 estradiol, age and follicle-stimulating hormone. Fertil Steril, 2005; 84: 795-797.